Form 4: FormFactor CEO Mike Slessor Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
FormFactor CEO Mike Slessor sold a total of 4,000 shares of common stock on December 2, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Mike Slessor, CEO of FormFactor Inc., sold 3,899 shares of common stock at a weighted average price of $40.57 per share on December 2, 2024.
- An additional 101 shares were sold at a weighted average price of $41.17 per share on the same day.
- These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 20, 2023.
- Following these sales, Slessor directly owns 526,531 shares of FormFactor common stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing for pre-planned stock sales by an executive, which is neither positive nor negative in itself.
Risks
- Sales by company executives can sometimes be perceived negatively by the market, although these sales were pre-planned.
Industry Context
Executive stock sales are a common occurrence, and the use of a 10b5-1 plan indicates that the sales were pre-planned and not based on any non-public information.
Comparison to Industry Standards
- Executive stock sales are a normal part of compensation and portfolio management across the technology industry.
- The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading, and is common among executives at companies like Applied Materials, Lam Research, and ASML.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price, but the pre-planned nature of the sales should mitigate any significant negative reaction.
Key Dates
| Date | Description |
|---|---|
| 2023-11-20 | Date the Rule 10b5-1 trading plan was adopted. |
| 2024-12-02 | Date of the stock sales. |
Keywords
FormFactor, Mike Slessor, insider trading, SEC Form 4, stock sale, Rule 10b5-1, executive
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.